UK's Advanced Medical Solutions H1 revenue rises 4%, adjusted profit up 11%

Advanced Medical Solutions

16/09/2026 07:13

Overview
UK tissue-healing tech firm's H1 revenue rose 4% year-on-year
Adjusted diluted EPS for H1 rose 10%, adjusted pretax profit up 11%
Reported pretax profit fell sharply due to exceptional restructuring and acquisition costs

Outlook
Company expects further progress in H2 2026, citing strong competitive position and end-market dynamics
Acquisition by H.B. Fuller expected to complete in Q4 2026, pending satisfaction of remaining conditions

Result Drivers
ORDER PHASING IMPACT - Lower Adhesives sales, especially LiquiBand in the US, due to prior year partner order phasing created a high comparator
CATEGORY MIX - Growth in Suture, Clips and VTO and Internal Fixation and Sealants, offsetting declines in Advanced Closure
RESTRUCTURING BENEFIT - Improved Woundcare performance and higher gross margins attributed to prior period restructuring initiatives

Company press release: ID:nRSP9080Ua

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
H1 Adjusted EPS
 
GBP 0.06
 
H1 Adjusted Pretax Profit
 
GBP 18.1 mln
 
H1 Pretax Profit
 
GBP 335,000
 

Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy"
Wall Street's median 12-month price target for Advanced Medical Solutions Group PLC is GBp285.00, about 1.4% above its September 15 closing price of GBp281.00
The stock recently traded at 18 times the next 12-month earnings vs. a P/E of 15 three months ago

Reuters Recommended Reads
Sept 15 - UK's Trustpilot shares slump as unchanged outlook disappoints investors
Sept 15 - UK's Wickes sees sales pick up as customers chase value
Sept 15 - GSK strikes up to $750 million deal for cancer-targeting drug

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)